Cargando…
Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach
SIMPLE SUMMARY: Early and accurate bladder cancer staging is important as it determines the mode of initial treatment. Non-muscle invasive bladder cancer (NMIBC) can be treated with transurethral resection whereas muscle invasive bladder cancer (MIBC) requires neoadjuvant chemotherapy with subsequen...
Autores principales: | Sarkar, Suryadipto, Min, Kong, Ikram, Waleed, Tatton, Ryan W., Riaz, Irbaz B., Silva, Alvin C., Bryce, Alan H., Moore, Cassandra, Ho, Thai H., Sonpavde, Guru, Abdul-Muhsin, Haidar M., Singh, Parminder, Wu, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046500/ https://www.ncbi.nlm.nih.gov/pubmed/36980557 http://dx.doi.org/10.3390/cancers15061673 |
Ejemplares similares
-
Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016) -
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
por: Thomas, Jonathan, et al.
Publicado: (2022) -
Precision Medicine to Treat Urothelial Carcinoma—The Way Forward
por: Luceno, Carvy Floyd, et al.
Publicado: (2023) -
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma
por: Ravi, Praful, et al.
Publicado: (2022) -
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
por: Velez, Miguel Gonzalez, et al.
Publicado: (2021)